|
1
|
Force LM, Kocarnik JM, May ML, Bhangdia K,
Crist A, Penberthy L, Pritchett N, Acheson A, Deitesfeld L, A A, et
al: The global, regional, and national burden of cancer, 1990–2023,
with forecasts to 2050: A systematic analysis for the global burden
of disease study 2023. Lancet. 406:1565–1586. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu B, Zhou H, Tan L, Siu KTH and Guan XY:
Exploring treatment options in cancer: Tumor treatment strategies.
Signal Transduct Target Ther. 9:1752024. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Anand U, Dey A, Chandel AKS, Sanyal R,
Mishra A, Pandey DK, De Falco V, Upadhyay A, Kandimalla R,
Chaudhary A, et al: Cancer chemotherapy and beyond: Current status,
drug candidates, associated risks and progress in targeted
therapeutics. Genes Dis. 10:1367–1401. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sun Q, Hong Z, Zhang C, Wang L, Han Z and
Ma D: Immune checkpoint therapy for solid tumours: Clinical
dilemmas and future trends. Signal Transduct Target Ther.
8:3202023. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu B, Zhang B, Li B, Wu H and Jiang M:
Cold and hot tumors: From molecular mechanisms to targeted therapy.
Signal Transduct Target Ther. 9:2742024. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Petitprez F, Meylan M, de Reynies A,
Sautès-Fridman C and Fridman WH: The tumor microenvironment in the
response to immune checkpoint blockade therapies. Front Immunol.
11:7842020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hatta MNA, Mohamad Hanif EA, Chin SF and
Neoh HM: Pathogens and carcinogenesis: A review. Biology (Basel).
10:5332021.PubMed/NCBI
|
|
8
|
Che S, Yan Z, Feng Y and Zhao H: Unveiling
the intratumoral microbiota within cancer landscapes. iScience.
27:1098932024. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Q, Zhao L, Han L, Fu G, Tuo X, Ma S,
Li Q, Wang Y, Liang D, Tang M, et al: The differential distribution
of bacteria between cancerous and noncancerous ovarian tissues in
situ. J Ovarian Res. 13:82020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Riquelme E, Zhang Y, Zhang L, Montiel M,
Zoltan M, Dong W, Quesada P, Sahin I, Chandra V, San Lucas A, et
al: Tumor microbiome diversity and composition influence pancreatic
cancer outcomes. Cell. 178:795–806.e12. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li Y, Chang RB, Stone ML, Delman D,
Markowitz K, Xue Y, Coho H, Herrera VM, Li JH, Zhang L, et al:
Multimodal immune phenotyping reveals microbial-T cell interactions
that shape pancreatic cancer. Cell Rep Med. 5:1013972024.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gao S, Li S, Ma Z, Liang S, Shan T, Zhang
M, Zhu X, Zhang P, Liu G, Zhou F, et al: Presence of
Porphyromonas gingivalis in esophagus and its association
with the clinicopathological characteristics and survival in
patients with esophageal cancer. Infect Agent Cancer. 11:32016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pushalkar S, Hundeyin M, Daley D,
Zambirinis CP, Kurz E, Mishra A, Mohan N, Aykut B, Usyk M, Torres
LE, et al: The pancreatic cancer microbiome promotes oncogenesis by
induction of innate and adaptive immune suppression. Cancer Discov.
8:403–416. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wen L, Mu W, Lu H, Wang X, Fang J, Jia Y,
Li Q, Wang D, Wen S, Guo J, et al: Porphyromonas gingivalis
promotes oral squamous cell carcinoma progression in an immune
microenvironment. J Dent Res. 99:666–675. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu CC, Grencewicz D, Chakravarthy K, Li
L, Liepold R, Wolf M, Sangwan N, Tzeng A, Hoyd R, Jhawar SR, et al:
Breast tumor microbiome regulates anti-tumor immunity and T
cell-associated metabolites. bioRxiv [Preprint]. 2024.10.29.620864.
2024.
|
|
16
|
Nejman D, Livyatan I, Fuks G, Gavert N,
Zwang Y, Geller LT, Rotter-Maskowitz A, Weiser R, Mallel G, Gigi E,
et al: The human tumor microbiome is composed of tumor
type-specific intracellular bacteria. Science. 368:973–980. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kalaora S, Nagler A, Nejman D, Alon M,
Barbolin C, Barnea E, Ketelaars SLC, Cheng K, Vervier K, Shental N,
et al: Identification of bacteria-derived HLA-bound peptides in
melanoma. Nature. 592:138–143. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chai X, Wang J, Li H, Gao C, Li S, Wei C,
Huang J, Tian Y, Yuan J, Lu J, et al: Intratumor microbiome
features reveal antitumor potentials of intrahepatic
cholangiocarcinoma. Gut Microbes. 15:21562552023. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tzeng A, Sangwan N, Jia M, Liu CC, Keslar
KS, Downs-Kelly E, Fairchild RL, Al-Hilli Z, Grobmyer SR and Eng C:
Human breast microbiome correlates with prognostic features and
immunological signatures in breast cancer. Genome Med. 13:602021.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yamamoto S, Kinugasa H, Hirai M, Terasawa
H, Yasutomi E, Oka S, Ohmori M, Yamasaki Y, Inokuchi T, Harada K,
et al: Heterogeneous distribution of Fusobacterium nucleatum
in the progression of colorectal cancer. J Gastroenterol Hepatol.
36:1869–1876. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Abe S, Masuda A, Matsumoto T, Inoue J,
Toyama H, Sakai A, Kobayashi T, Tanaka T, Tsujimae M, Yamakawa K,
et al: Impact of intratumoral microbiome on tumor immunity and
prognosis in human pancreatic ductal adenocarcinoma. J
Gastroenterol. 59:250–262. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang G, Wang H, Ji X, Wang T, Zhang Y,
Jiang W, Meng L, Wu HJ, Xing X and Ji J: Intratumoral microbiome is
associated with gastric cancer prognosis and therapy efficacy. Gut
Microbes. 16:23693362024. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li L, He S, Liao B, Wang M, Lin H, Hu B,
Lan X, Shu Z, Zhang C, Yu M and Zou Z: Orally administrated
hydrogel harnessing intratumoral microbiome and microbiota-related
immune responses for potentiated colorectal cancer treatment.
Research (Wash D C). 7:03642024.PubMed/NCBI
|
|
24
|
Peng R, Liu S, You W, Huang Y, Hu C, Gao
Y, Jia X, Li G, Xu Z and Chen Y: Gastric microbiome alterations are
associated with decreased CD8+ tissue-resident memory T cells in
the tumor microenvironment of gastric cancer. Cancer Immunol Res.
10:1224–1240. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liao Y, Wu YX, Tang M, Chen YW, Xie JR, Du
Y, Wang TM, He YQ, Xue WQ, Zheng XH, et al: Microbes translocation
from oral cavity to nasopharyngeal carcinoma in patients. Nat
Commun. 15:16452024. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yeo K, Connell J, Bouras G, Smith E,
Murphy W, Hodge JC, Krishnan S, Wormald PJ, Valentine R, Psaltis
AJ, et al: A comparison between full-length 16S rRNA Oxford
nanopore sequencing and Illumina V3-V4 16S rRNA sequencing in head
and neck cancer tissues. Arch Microbiol. 206:2482024. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Battaglia TW, Mimpen IL, Traets JJH, van
Hoeck A, Zeverijn LJ, Geurts BS, de Wit GF, Noë M, Hofland I, Vos
JL, et al: A pan-cancer analysis of the microbiome in metastatic
cancer. Cell. 187:2324–2335.e19. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Debesa-Tur G, Pérez-Brocal V, Ruiz-Ruiz S,
Castillejo A, Latorre A, Soto JL and Moya A: Metagenomic analysis
of formalin-fixed paraffin-embedded tumor and normal mucosa reveals
differences in the microbiome of colorectal cancer patients. Sci
Rep. 11:3912021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sun Y, Gan Z, Wang X, Liu J, Zhong W,
Zhang Z, Zuo J, Zhong H, Huang X, Yan Z and Cao Q: Integrative
metagenomic, transcriptomic, and proteomic analysis reveal the
microbiota-host interplay in early-stage lung adenocarcinoma among
non-smokers. J Transl Med. 22:6522024. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Seferbekova Z, Lomakin A, Yates LR and
Gerstung M: Spatial biology of cancer evolution. Nat Rev Genet.
24:295–313. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lyu L, Li X, Feng R, Zhou X, Guha TK, Yu
X, Chen GQ, Yao Y, Su B, Zou D, et al: Simultaneous profiling of
host expression and microbial abundance by spatial
metatranscriptome sequencing. Genome Res. 33:401–411. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xu H, Leng J, Liu F, Chen T, Qu J, Yang Y,
Ning C, Ke X, Xiao B, Zhang Y and Sun L: Tumor microbiota of renal
cell carcinoma affects clinical prognosis by influencing the tumor
immune microenvironment. Heliyon. 10:e383102024. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gur C, Ibrahim Y, Isaacson B, Yamin R,
Abed J, Gamliel M, Enk J, Bar-On Y, Stanietsky-Kaynan N,
Coppenhagen-Glazer S, et al: Binding of the Fap2 protein of
Fusobacterium nucleatum to human inhibitory receptor TIGIT
protects tumors from immune cell attack. Immunity. 42:344–355.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu Y, Wong CC, Ding Y, Gao M, Wen J, Lau
HC, Cheung AH, Huang D, Huang H and Yu J: Peptostreptococcus
anaerobius mediates anti-PD1 therapy resistance and exacerbates
colorectal cancer via myeloid-derived suppressor cells in mice. Nat
Microbiol. 9:1467–1482. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Singhal N, Kumar M, Kanaujia PK and Virdi
JS: MALDI-TOF mass spectrometry: an emerging technology for
microbial identification and diagnosis. Front Microbiol. 6:7912015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Galeano Niño JL, Wu H, LaCourse KD,
Kempchinsky AG, Baryiames A, Barber B, Futran N, Houlton J, Sather
C, Sicinska E, et al: Effect of the intratumoral microbiota on
spatial and cellular heterogeneity in cancer. Nature. 611:810–817.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Song Y, Peng Y, Qin C, Jiang S, Lin J, Lai
S, Wu J, Ding M, Du Y, Yu L and Xu T: Antibiotic use attenuates
response to immune checkpoint blockade in urothelial carcinoma via
inhibiting CD74-MIF/COPA: Revealing cross-talk between
anti-bacterial immunity and ant-itumor immunity. Int J Surg.
111:972–987. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Fukuda K, Ogawa M, Taniguchi H and Saito
M: Molecular approaches to studying microbial communities:
Targeting the 16S ribosomal RNA gene. J UOEH. 38:223–232. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu W, Xu J, Pi Z, Chen Y, Jiang G, Wan Y
and Mao W: Untangling the web of intratumor microbiota in lung
cancer. Biochim Biophys Acta Rev Cancer. 1878:1890252023.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fu A, Yao B, Dong T, Chen Y, Yao J, Liu Y,
Li H, Bai H, Liu X, Zhang Y, et al: Tumor-resident intracellular
microbiota promotes metastatic colonization in breast cancer. Cell.
185:1356–1372.e26. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Cullin N, Azevedo Antunes C, Straussman R,
Stein-Thoeringer CK and Elinav E: Microbiome and cancer. Cancer
Cell. 39:1317–1341. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kim C, Pongpanich M and Porntaveetus T:
Unraveling metagenomics through long-read sequencing: A
comprehensive review. J Transl Med. 22:1112024. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Oehler JB, Wright H, Stark Z, Mallett AJ
and Schmitz U: The application of long-read sequencing in clinical
settings. Hum Genomics. 17:732023. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ntekas I, Takayasu L, McKellar DW, Grodner
BM, Holdener C, Schweitzer P, Sauthoff M, Shi Q, Brito IL and De
Vlaminck I: High resolution spatial mapping of microbiome-host
interactions via in situ polyadenylation and spatial RNA
sequencing. bioRxiv. 2024.2011.2018.624127. 2024.
|
|
45
|
Qiao H, Tan XR, Li H, Li JY, Chen XZ, Li
YQ, Li WF, Tang LL, Zhou GQ, Zhang Y, et al: Association of
intratumoral microbiota with prognosis in patients with
nasopharyngeal carcinoma from 2 hospitals in China. JAMA Oncol.
8:1301–1309. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Galeano Niño JL, Ponath F, Ajisafe VA,
Becker CR, Kempchinsky AG, Zepeda-Rivera MA, Gomez JA, Wu H,
Terrazas JG, Bouzek H, et al: Tumor-infiltrating bacteria disrupt
cancer epithelial cell interactions and induce cell-cycle arrest.
Cancer Cell. 44:166–186.e16. 2026. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Bullman S: INVADEseq to study the
intratumoural microbiota at host single-cell resolution. Nat Rev
Cancer. 23:1892023. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Robinson W, Stone JK, Schischlik F, Gasmi
B, Kelly MC, Seibert C, Dadkhah K, Gertz EM, Lee JS, Zhu K, et al:
Identification of intracellular bacteria from multiple single-cell
RNA-seq platforms using CSI-microbes. Sci Adv. 10:eadj74022024.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Chung L, Thiele Orberg E, Geis AL, Chan
JL, Fu K, DeStefano Shields CE, Dejea CM, Fathi P, Chen J, Finard
BB, et al: Bacteroides fragilis toxin coordinates a
pro-carcinogenic inflammatory cascade via targeting of colonic
epithelial cells. Cell Host Microbe. 23:203–214.e5. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wang X, Fang Y, Liang W, Wong CC, Qin H,
Gao Y, Liang M, Song L, Zhang Y, Fan M, et al: Fusobacterium
nucleatum facilitates anti-PD-1 therapy in microsatellite
stable colorectal cancer. Cancer Cell. 42:1729–1746.e8. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Lattanzi G, Strati F, Díaz-Basabe A,
Perillo F, Amoroso C, Protti G, Rita Giuffrè M, Iachini L, Baeri A,
Baldari L, et al: iNKT cell-neutrophil crosstalk promotes
colorectal cancer pathogenesis. Mucosal Immunol. 16:326–340. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wang X, Jia Y, Wen L, Mu W, Wu X, Liu T,
Liu X, Fang J, Luan Y, Chen P, et al: Porphyromonas
gingivalis promotes colorectal carcinoma by activating the
hematopoietic NLRP3 inflammasome. Cancer Res. 81:2745–2759. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Li Q, Wu W, Gong D, Shang R, Wang J and Yu
H: Propionibacterium acnes overabundance in gastric cancer
promote M2 polarization of macrophages via a TLR4/PI3K/Akt
signaling. Gastric Cancer. 24:1242–1253. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Nie F, Zhang J, Tian H, Zhao J, Gong P,
Wang H, Wang S, Yang P and Yang C: The role of CXCL2-mediated
crosstalk between tumor cells and macrophages in Fusobacterium
nucleatum-promoted oral squamous cell carcinoma progression.
Cell Death Dis. 15:2772024. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Tan Q, Ma X, Yang B, Liu Y, Xie Y, Wang X,
Yuan W and Ma J: Periodontitis pathogen Porphyromonas
gingivalis promotes pancreatic tumorigenesis via neutrophil
elastase from tumor-associated neutrophils. Gut Microbes.
14:20737852022. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Amieva M and Peek RM Jr: Pathobiology of
Helicobacter pylori-induced gastric cancer.
Gastroenterology. 150:64–78. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Guo Y, Cao XS, Zhou MG and Yu B: Gastric
microbiota in gastric cancer: Different roles of Helicobacter
pylori and other microbes. Front Cell Infect Microbiol.
12:11058112023. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Zeng R, Gou H, Lau HCH and Yu J: Stomach
microbiota in gastric cancer development and clinical implications.
Gut. 73:2062–2073. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Ding M, Zhang T, Li S, Zhang Y, Qiu Y and
Zhang B: Correlation analysis between liver metastasis and serum
levels of miR-200 and miR-141 in patients with colorectal cancer.
Mol Med Rep. 16:7791–7795. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Yu G, Torres J, Hu N, Medrano-Guzman R,
Herrera-Goepfert R, Humphrys MS, Wang L, Wang C, Ding T, Ravel J,
et al: Molecular characterization of the human stomach microbiota
in gastric cancer patients. Front Cell Infect Microbiol. 7:3022017.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Liu X, Shao L, Liu X, Ji F, Mei Y, Cheng
Y, Liu F, Yan C, Li L and Ling Z: Alterations of gastric mucosal
microbiota across different stomach microhabitats in a cohort of
276 patients with gastric cancer. EBioMedicine. 40:336–348. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Zhang T, Li Y, Zhai E, Zhao R, Qian Y,
Huang Z, Liu Y, Zhao Z, Xu X, Liu J, et al: Intratumoral
Fusobacterium nucleatum recruits tumor-associated
neutrophils to promote gastric cancer progression and immune
evasion. Cancer Res. 85:1819–1841. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Fu K, Cheung AHK, Wong CC, Liu W, Zhou Y,
Wang F, Huang P, Yuan K, Coker OO, Pan Y, et al: Streptococcus
anginosus promotes gastric inflammation, atrophy, and
tumorigenesis in mice. Cell. 187:882–896.e17. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Yuan L, Pan L, Wang Y, Zhao J, Fang L,
Zhou Y, Xia R, Ma Y, Jiang Z, Xu Z, et al: Characterization of the
landscape of the intratumoral microbiota reveals that
Streptococcus anginosus increases the risk of gastric cancer
initiation and progression. Cell Discov. 10:1172024. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Neurath MF, Artis D and Becker C: The
intestinal barrier: A pivotal role in health, inflammation, and
cancer. Lancet Gastroenterol Hepatol. 10:573–592. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Yang L, Li A, Wang Y and Zhang Y:
Intratumoral microbiota: Roles in cancer initiation, development
and therapeutic efficacy. Signal Transduct Target Ther. 8:352023.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Zitvogel L, Galluzzi L, Viaud S, Vétizou
M, Daillère R, Merad M and Kroemer G: Cancer and the gut
microbiota: An unexpected link. Sci Transl Med. 7:271ps12015.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Man SM, Zhu Q, Zhu L, Liu Z, Karki R,
Malik A, Sharma D, Li L, Malireddi RK, Gurung P, et al: Critical
role for the DNA sensor AIM2 in stem cell proliferation and cancer.
Cell. 162:45–58. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Okuda S, Shimada Y, Tajima Y, Yuza K,
Hirose Y, Ichikawa H, Nagahashi M, Sakata J, Ling Y, Miura N, et
al: Profiling of host genetic alterations and intra-tumor
microbiomes in colorectal cancer. Comput Struct Biotechnol J.
19:3330–3338. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Guan X, Bu F, Fu Y, Zhang H, Xiang H, Chen
X, Chen T, Wu X, Wu K, Liu L and Dong X: Immunogenic peptides
putatively from intratumor microbes: Opportunities for colorectal
cancer treatment. iScience. 27:1113382024. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Gu J, Xu X, Li X, Yue L, Zhu X, Chen Q,
Gao J, Takashi M, Zhao W, Zhao B, et al: Tumor-resident microbiota
contributes to colorectal cancer liver metastasis by lactylation
and immune modulation. Oncogene. 43:2389–2404. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Bertocchi A, Carloni S, Ravenda PS,
Bertalot G, Spadoni I, Lo Cascio A, Gandini S, Lizier M, Braga D,
Asnicar F, et al: Gut vascular barrier impairment leads to
intestinal bacteria dissemination and colorectal cancer metastasis
to liver. Cancer Cell. 39:708–724.e11. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Shi Y, Zheng W, Yang K, Harris KG, Ni K,
Xue L, Lin W, Chang EB, Weichselbaum RR and Fu YX: Intratumoral
accumulation of gut microbiota facilitates CD47-based immunotherapy
via STING signaling. J Exp Med. 217:e201922822020. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Xie M, Yuan K, Zhang Y, Zhang Y, Zhang R,
Gao J, Wei W, Jiang L, Li T, Ding Y, et al: Tumor-resident
probiotic Clostridium butyricum improves aPD-1 efficacy in
colorectal cancer models by inhibiting IL-6-mediated
immunosuppression. Cancer Cell. 43:1885–1901.e10. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Hu JX, Zhao CF, Chen WB, Liu QC, Li QW,
Lin YY and Gao F: Pancreatic cancer: A review of epidemiology,
trend, and risk factors. World J Gastroenterol. 27:4298–4321. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Geller LT, Barzily-Rokni M, Danino T,
Jonas OH, Shental N, Nejman D, Gavert N, Zwang Y, Cooper ZA, Shee
K, et al: Potential role of intratumor bacteria in mediating tumor
resistance to the chemotherapeutic drug gemcitabine. Science.
357:1156–1160. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Ghaddar B, Biswas A, Harris C, Omary MB,
Carpizo DR, Blaser MJ and De S: Tumor microbiome links cellular
programs and immunity in pancreatic cancer. Cancer Cell.
40:1240–1253.e5. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Han ZY, Fu ZJ, Wang YZ, Zhang C, Chen QW,
An JX and Zhang XZ: Probiotics functionalized with a
gallium-polyphenol network modulate the intratumor microbiota and
promote anti-tumor immune responses in pancreatic cancer. Nat
Commun. 15:70962024. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Chiang HC, Hughes M and Chang WL: The role
of microbiota in esophageal squamous cell carcinoma: A review of
the literature. Thorac Cancer. 14:2821–2829. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Yang W, Chen CH, Jia M, Xing X, Gao L,
Tsai HT, Zhang Z, Liu Z, Zeng B, Yeung SJ, et al: Tumor-associated
microbiota in esophageal squamous cell carcinoma. Front Cell Dev
Biol. 9:6412702021. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Greathouse KL, Stone JK, Vargas AJ,
Choudhury A, Padgett RN, White JR, Jung A and Harris CC:
Co-enrichment of cancer-associated bacterial taxa is correlated
with immune cell infiltrates in esophageal tumor tissue. Sci Rep.
14:25742024. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Yamamura K, Baba Y, Nakagawa S, Mima K,
Miyake K, Nakamura K, Sawayama H, Kinoshita K, Ishimoto T, Iwatsuki
M, et al: Human microbiome Fusobacterium nucleatum in
esophageal cancer tissue is associated with prognosis. Clin Cancer
Res. 22:5574–5581. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Yamamura K, Izumi D, Kandimalla R,
Sonohara F, Baba Y, Yoshida N, Kodera Y, Baba H and Goel A:
Intratumoral Fusobacterium nucleatum levels predict
therapeutic response to neoadjuvant chemotherapy in esophageal
squamous cell carcinoma. Clin Cancer Res. 25:6170–6179. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Gao S, Liu Y, Duan X, Liu K, Mohammed M,
Gu Z, Ren J, Yakoumatos L, Yuan X, Lu L, et al: Porphyromonas
gingivalis infection exacerbates oesophageal cancer and
promotes resistance to neoadjuvant chemotherapy. Br J Cancer.
125:433–444. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Wu H, Leng X, Liu Q, Mao T, Jiang T, Liu
Y, Li F, Cao C, Fan J, Chen L, et al: Intratumoral microbiota
composition regulates chemoimmunotherapy response in esophageal
squamous cell carcinoma. Cancer Res. 83:3131–3144. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Smith A, Pierre JF, Makowski L, Tolley E,
Lyn-Cook B, Lu L, Vidal G and Starlard-Davenport A: Distinct
microbial communities that differ by race, stage, or breast-tumor
subtype in breast tissues of non-Hispanic Black and non-Hispanic
White women. Sci Rep. 9:119402019. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Wang H, Rong X, Zhao G, Zhou Y, Xiao Y, Ma
D, Jin X, Wu Y, Yan Y, Yang H, et al: The microbial metabolite
trimethylamine N-oxide promotes antitumor immunity in
triple-negative breast cancer. Cell Metab. 34:581–594.e8. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Laborda-Illanes A, Aranega-Martín L,
Sánchez-Alcoholado L, Boutriq S, Plaza-Andrades I, Peralta-Linero
J, Garrido Ruiz G, Pajares-Hachero B, Álvarez M, Alba E, et al:
Exploring the relationship between MicroRNAs, intratumoral
microbiota, and breast cancer progression in patients with and
without metastasis. Int J Mol Sci. 25:70912024. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Parhi L, Alon-Maimon T, Sol A, Nejman D,
Shhadeh A, Fainsod-Levi T, Yajuk O, Isaacson B, Abed J, Maalouf N,
et al: Breast cancer colonization by Fusobacterium nucleatum
accelerates tumor growth and metastatic progression. Nat Commun.
11:32592020. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Cao Y, Xia H, Tan X, Shi C, Ma Y, Meng D,
Zhou M, Lv Z, Wang S and Jin Y: Intratumoural microbiota: A new
frontier in cancer development and therapy. Signal Transduct Target
Ther. 9:152024. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Mao Q, Jiang F, Yin R, Wang J, Xia W, Dong
G, Ma W, Yang Y, Xu L and Hu J: Interplay between the lung
microbiome and lung cancer. Cancer Lett. 415:40–48. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Yu G, Gail MH, Consonni D, Carugno M,
Humphrys M, Pesatori AC, Caporaso NE, Goedert JJ, Ravel J and Landi
MT: Characterizing human lung tissue microbiota and its
relationship to epidemiological and clinical features. Genome Biol.
17:1632016. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Gomes S, Cavadas B, Ferreira JC, Marques
PI, Monteiro C, Sucena M, Sousa C, Vaz Rodrigues L, Teixeira G,
Pinto P, et al: Profiling of lung microbiota discloses differences
in adenocarcinoma and squamous cell carcinoma. Sci Rep.
9:128382019. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Zhang M, Zhang Y, Sun Y, Wang S, Liang H
and Han Y: Intratumoral microbiota impacts the first-line treatment
efficacy and survival in non-small cell lung cancer patients free
of lung infection. J Healthc Eng. 2022:54668532022.PubMed/NCBI
|
|
95
|
Wong-Rolle A, Dong Q, Zhu Y, Divakar P,
Hor JL, Kedei N, Wong M, Tillo D, Conner EA, Rajan A, et al:
Spatial meta-transcriptomics reveal associations of intratumor
bacteria burden with lung cancer cells showing a distinct oncogenic
signature. J Immunother Cancer. 10:e0046982022. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Elkrief A, Montesion M, Sivakumar S, Hale
C, Bowman AS, Begüm Bektaş A, Bradic M, Kang W, Chan E, Gogia P, et
al: Intratumoral escherichia is associated with improved survival
to single-agent immune checkpoint inhibition in patients with
advanced non-small-cell lung cancer. J Clin Oncol. 42:3339–3349.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Zhu G, Su H, Johnson CH, Khan SA, Kluger H
and Lu L: Intratumour microbiome associated with the infiltration
of cytotoxic CD8+ T cells and patient survival in cutaneous
melanoma. Eur J Cancer. 151:25–34. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Irfan M, Delgado RZR and Frias-Lopez J:
The oral microbiome and cancer. Front Immunol. 11:5910882020.
View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Panebianco C, Andriulli A and Pazienza V:
Pharmacomicrobiomics: Exploiting the drug-microbiota interactions
in anticancer therapies. Microbiome. 6:922018. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Lehouritis P, Cummins J, Stanton M, Murphy
CT, McCarthy FO, Reid G, Urbaniak C, Byrne WL and Tangney M: Local
bacteria affect the efficacy of chemotherapeutic drugs. Sci Rep.
5:145542015. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Boesch M, Baty F, Albrich WC, Flatz L,
Rodriguez R, Rothschild SI, Joerger M, Früh M and Brutsche MH:
Local tumor microbial signatures and response to checkpoint
blockade in non-small cell lung cancer. Oncoimmunology.
10:19884032021. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Zheng J and Chen H: Effects of
intratumoral microbiota on tumorigenesis, anti-tumor immunity, and
microbe-based cancer therapy. Front Oncol. 14:14297222024.
View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Chen J, Li T, Liang J, Huang Q, Huang JD,
Ke Y and Sun H: Current status of intratumour microbiome in cancer
and engineered exogenous microbiota as a promising therapeutic
strategy. Biomed Pharmacother. 145:1124432022. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Ijaz M, Hasan I, Chaudhry TH, Huang R,
Zhang L, Hu Z, Tan Q and Guo B: Bacterial derivatives mediated drug
delivery in cancer therapy: A new generation strategy. J
Nanobiotechnology. 22:5102024. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Shen H, Zhang C, Li S, Liang Y, Lee LT,
Aggarwal N, Wun KS, Liu J, Nadarajan SP, Weng C, et al:
Prodrug-conjugated tumor-seeking commensals for targeted cancer
therapy. Nat Commun. 15:43432024. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Goto Y, Iwata S, Miyahara M and Miyako E:
Discovery of intratumoral oncolytic bacteria toward targeted
anticancer theranostics. Adv Sci (Weinh). 10:23016792023.
View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Zheng DW, Li RQ, An JX, Xie TQ, Han ZY, Xu
R, Fang Y and Zhang XZ: Prebiotics-encapsulated probiotic spores
regulate gut microbiota and suppress colon cancer. Adv Mater.
32:e20045292020. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Li M, Li T, Liu Y, Han D, Wu S and Gong J:
Dual-targeted biomimetic hybrid nanovesicles for tumor
microenvironment reprogramming and intratumoral bacteria
eradication in triple-negative breast cancer. Adv Funct Mater.
36:e106952026. View Article : Google Scholar
|
|
109
|
Xu W, Hao X, Tang Y, Peng Y, Liu X, Zhou
M, Han R, Wu J and Xiang D: Inflammation-driven doxycycline-glucose
oxidase nanoparticle induce starvation-/chemodynamic-/immunotherapy
against intratumoral bacteria-assisted tumor development. Adv Funct
Mater. 35:24221962025. View Article : Google Scholar
|
|
110
|
Geng S, Guo P, Li X, Shi Y, Wang J, Cao M,
Zhang Y, Zhang K, Li A, Song H, et al: Biomimetic
nanovehicle-enabled targeted depletion of intratumoral
Fusobacterium nucleatum synergizes with PD-L1 blockade
against breast cancer. ACS Nano. 18:8971–8987. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Chen L, Kang Z, Shen J, Zhao R, Miao Y,
Zhang L, Zheng Z, Zhang Z, Liu N, Wang C, et al: An emerging
antibacterial nanovaccine for enhanced chemotherapy by selectively
eliminating tumor-colonizing bacteria. Sci Bull (Beijing).
69:2565–2579. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Wang C, Zhong L, Xu J, Zhuang Q, Gong F,
Chen X, Tao H, Hu C, Huang F, Yang N, et al: Oncolytic mineralized
bacteria as potent locally administered immunotherapeutics. Nat
Biomed Eng. 8:561–578. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Liu X, Sun M, Pu F, Ren J and Qu X:
Transforming intratumor bacteria into immunopotentiators to reverse
cold tumors for enhanced immuno-chemodynamic therapy of
triple-negative breast cancer. J Am Chem Soc. 145:26296–26307.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Zhang J, Wan S, Zhou H, Du J, Li Y, Zhu H,
Weng L, Ding X and Wang L: Programmed nanocloak of commensal
bacteria-derived nanovesicles amplify strong immunoreactivity
against tumor growth and metastatic progression. ACS Nano.
18:9613–9626. 2024. View Article : Google Scholar : PubMed/NCBI
|
